This in-depth expert article compares HMB-Ca and yeast protein as next-generation actives for muscle–skin axis body lotions targeting sarcopenia-related skin sagging. It covers mechanisms, formulation strategy, and OEM/ODM opportunities with biofermentation-driven manufacturers.
